AzTrials
AzTrials

Cerebral PerfusionNCT03302130

The Effects of Mood on Cerebral Perfusion

A study testing Mood induction (using own memories), Arterial spin labeling MRI and Physiological monitoring in people with Cerebral Perfusion, run by University Ghent.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the effects of a different mood state (neutral, positive and negative mood), induced using subjects own memories, on both global and regional… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Cerebral Perfusion
What is being tested?
Mood induction (using own memories), Arterial spin labeling MRI and Physiological monitoring
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
No sites listed yet
Study dates
8 Jan 2016to 17 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy university students
  • between 18 and 30 years old

Who cannot join

  • No informed consent
  • Not using hormonal contraception
  • MRI-contraindications
  • Claustrophobia
  • Pregnancy
  • Chronic diseases and chronic medication use

About this study

Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the effects of a different mood state (neutral, positive and negative mood), induced using subjects own memories, on both global and regional cerebral perfusion, measured with arterial spin labeling.

Being tested
Mood induction (using own memories), Arterial spin labeling MRI, Physiological monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mood induction (using own memories)Behavioural

    Subjects deliver three positive, three negative and three neutral memories 30 seconds reliving a memory - answering questions about the memory - reliving memory for 2 minutes during ASL-MRI

  • Arterial spin labeling MRIDevice

    Single PLD PCASL

  • Physiological monitoringDevice

    During MRI: heart rate, end-tidal CO2, respiratory rate and skin conductance

Study groups in NCT03302130
Study groupRoleWhat they receive
Imaging healthy volunteersExperimentalMood induction: positive, negative, neutral mood (using subjects own memories) Arterial spin labeling MRI Physiological monitoring
Receives: Behavioral: Mood induction (using own memories); Device: Arterial spin labeling MRI; Device: Physiological monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Regional Cerebral perfusion (ml/100g/min) during positive mood induction

    Effect of positive mood induction (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan during mood state induction)

  2. Regional Cerebral perfusion (ml/100g/min) during negative mood induction

    Effect of negative mood induction (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan during mood state induction)

  3. Regional Cerebral perfusion (ml/100g/min) during neutral mood induction

    Effect of neutral mood induction (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan during mood state induction)

  4. Regional Cerebral perfusion (ml/100g/min) after positive mood induction

    Effect of positive mood (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan after mood state induction)

  5. Regional Cerebral perfusion (ml/100g/min) after negative mood induction

    Effect of negative mood (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan after mood state induction)

  6. Regional Cerebral perfusion (ml/100g/min) after neutral mood induction

    Effect of neutral mood (using volunteer's own memories) on cerebral perfusion using arterial spin labeling MRI.

    Measured: 2 minutes (ASL scan after mood state induction)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2017
  2. Study start8 Jan 2016
  3. Primary completion30 Oct 2017
  4. Study completion17 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03302130
Sponsor's protocol ID
EC/2015/0528
Status last verified
Nov 2022
First submitted
6 Oct 2016
Last updated
14 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mood induction (using own memories), Arterial spin labeling MRI and Physiological monitoring in people with Cerebral Perfusion, run by University Ghent.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Regional Cerebral perfusion (ml/100g/min) during positive mood induction (time frame: 2 minutes (ASL scan during mood state induction)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in